These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38254201)

  • 1. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
    Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
    Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy.
    Takahashi J; Nagasawa S; Doi M; Takahashi M; Narita Y; Yamamoto J; Ikemoto MJ; Iwahashi H
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial.
    Mikic N; Poulsen FR; Kristoffersen KB; Laursen RJ; Guldberg TL; Skjøth-Rasmussen J; Wong ET; Møller S; Dahlrot RH; Sørensen JCH; Korshøj AR
    BMC Cancer; 2021 Sep; 21(1):1010. PubMed ID: 34503460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
    Lesueur P; Lequesne J; Grellard JM; Dugué A; Coquan E; Brachet PE; Geffrelot J; Kao W; Emery E; Berro DH; Castera L; Goardon N; Lacroix J; Lange M; Capel A; Leconte A; Andre B; Léger A; Lelaidier A; Clarisse B; Stefan D
    BMC Cancer; 2019 Mar; 19(1):198. PubMed ID: 30832617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies.
    Stummer W; Müther M; Spille D
    Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
    Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N
    J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review.
    Nordmann NJ; Michael AP
    Clin Neurol Neurosurg; 2021 Feb; 201():106430. PubMed ID: 33360951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
    Thivat E; Casile M; Moreau J; Molnar I; Dufort S; Seddik K; Le Duc G; De Beaumont O; Loeffler M; Durando X; Biau J
    BMC Cancer; 2023 Apr; 23(1):344. PubMed ID: 37060055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial.
    Hudson EM; Noutch S; Webster J; Brown SR; Boele FW; Al-Salihi O; Baines H; Bulbeck H; Currie S; Fernandez S; Hughes J; Lilley J; Smith A; Parbutt C; Slevin F; Short S; Sebag-Montefiore D; Murray L
    BMJ Open; 2024 Mar; 14(3):e078926. PubMed ID: 38458809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of
    Yang DM; Cvetkovic D; Chen L; Ma CC
    Biomed Phys Eng Express; 2022 Nov; 8(6):. PubMed ID: 36263662
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial.
    Dupont C; Vermandel M; Leroy HA; Quidet M; Lecomte F; Delhem N; Mordon S; Reyns N
    Neurosurgery; 2019 Jun; 84(6):E414-E419. PubMed ID: 30053213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
    Geletneky K; Huesing J; Rommelaere J; Schlehofer JR; Leuchs B; Dahm M; Krebs O; von Knebel Doeberitz M; Huber B; Hajda J
    BMC Cancer; 2012 Mar; 12():99. PubMed ID: 22436661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
    Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
    Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.